Clozapine-induced urinary incontinence: Incidence and treatment with ephedrine

Journal of Clinical Psychiatry

Volumn 57, Issue 11, 1996, Pages 514-518

  Fuller, Matthew A ^a,b   Borovicka, Mary C ^a   Jaskiw, George E ^a   Simon, Michelle R ^a   Kwon, Kong ^a   Konicki, P Eric ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Pharmacy Service 119(B)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMANTADINE; BENZATROPINE; BENZATROPINE MESILATE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DOXAZOSIN; EPHEDRINE; HALOPERIDOL; NEUROLEPTIC AGENT; OXYBUTYNIN; PROPRANOLOL; TRIHEXYPHENIDYL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK FACTOR; SCHIZOIDISM; SCHIZOPHRENIA; URINE INCONTINENCE;

EID: 0029819991     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v57n1102     Document Type: Article

References (26)

1. Warner JP, Harvey CA, Barnes TRE. Clozapine and urinary incontinence. Int Clin Psychopharmacol 1994;9:207-209
2. Berrios OE. Temporary urinary incontinence in the acute psychiatric patient without delirium or dementia. Br J Psychiatry 1986;149:224-227
3. Ambrosini PJ. A pharmacological paradigm for urinary incontinence and enuresis. J Clin Psychopharmacol 1984;4:247-253
4. Gittelman-Klein R, Klein DF, Katz S, et al. Comparative effects of methyl-phenidate and thioridazine in hyperactive children. Arch Gen Psychiatry 1976;33:1217-1231
5. Pollack MH, Reiter JS, Hammerness P. Genitourinary and sexual adverse effects of psychotropic medication. Int J Psychiatry Med 1992;22(4):305-327
6. Shriqui CL. Treatment of clozapine-induced enuresis with desmopressin [abstract]. Schizophr Res 1993;9:251
7. Kuchenhoff B. Die wichtigsten Nebenwirkungen unter Clozapin (Leponex) und ihre Behandlung. Psychiatr Prax 1993;20:201-206
8. Merschel A, Oberle J, Rangoni F. La clozapine effects indesirables: etude dans les C.H.S. de la Region Alsace. La Pharmacie Hospitaliere Francaise 1993;106:231-242
9. Raz S. Pharmacological treatment of lower urinary tract dysfunction. Urol Clin N Am 1978;5(2):323-334
10. Westmore DD. Urinary incontinence: which drugs to use. Drugs 1979;17: 418-422
11. Van Putten T, Malkin M, Weiss MS. Phenothiazine-induced stress incontinence. J Urol 1973;109:625-626
12. Baldessarini RJ, Frankeaburg FR. Clozapine: a novel antipsychotic agent. N Engl J Med 1991;324:746-754
13. Andersson KE. Clinical relevance of some findings in neuro-anatomy and neurophysiology of the lower urinary tract. Clin Sci (Colch) 1986;70 (suppl 14):21s-32s
14. Hoffman BB, Lefkowitz RJ. Catecholamines and sympathomimetic drugs. In: Gilman AG, Rall TW, Nies AS, et al, eds. Goodman and Gibman's The Pharmacological Basis of Therapeutics. 8th ed. Elmsford, NY: Pergamon Press; 1990:187-220
15. Whithouse AM, Duncan JM. Ephedrine psychosis rediscovered. Br J Psychiatry 1987;150:258-261
16. Lambert MT. Paranoid psychosis after abuse of proprietary cold remedies. Br J Psychiatry 1987;151:548-550
17. Wood KA. Nasal decongestant and psychiatric disturbances [letter]. Br J Psychiatry 1994;16:566-567
18. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-796
19. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812
20. Poyurovsky M, Modai I, Weizman A. Trihexyphenidyl as a possible therapeutic option in clozapine-induced nocturnal enuresis. Int Clin Psychopharmacol 1996;11:61-63
21. Lindstrom LH. The effect of long term treatment of clozapine in schizophrenia: a retrospective study of % patients treated with clozapine for up to 13 years. Acta Psychiatr Scand 1988;77:524-529
22. Lieberman JA, Kane JM, Johns CA. Clozapine: guidelines for clinical management. J Clin Psychiatry 1989;50:329-338
23. Jaskiw GE, Weinberger DR. Dopamine and schizophrenia: a cortically corrective perspective. Seminars in Neurosciences 1992;4:179-188
24. Davis KL, Kahn RS, Ko G, et al. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 1991;148:1474-1486
25. Heritch AJ. Evidence for reduced and dysregulated turnover of dopamine in schizophrenia. Schizophr Bull 1990;16:605-615
26. Clozaril (clozapine). Physicians' Desk Reference. 50th ed. Montvale, NJ: Medical Economics; 1996:2252-2256